Although the trial provides hope, one of the researchers leading the project urged people to continue heeding social distancing guidelines.
By Keir Simmons, Linda Givetash and Laura Saravia
LONDON — An experimental vaccine for COVID-19 under development at Oxford University hit a milestone Friday with researchers announcing it will be progressing to advanced stages of human trials.
It will be tested in 10,260 volunteers across the United Kingdom to determine how effective it is at preventing infection, the university said in a statement. If successful, it could be on the market as early as September, according to British-Swedish drugmaker AstraZeneca, which partnered with the university in April to manufacture and distribute the vaccine.